City Therapeutics

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Averna Therapeutics

This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.

ADARx Pharmaceuticals

This clinical-stage biotechnology company develops RNA-targeting therapeutics for patients with genetic, cardiometabolic, complement-mediated, and central nervous system diseases.

Crucible Therapeutics

This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Moonwalk Therapeutics

This biotechnology company develops epigenetic and RNA interference medicines to treat obesity and cardiometabolic diseases for patients.

Dicerna

This biotechnology firm develops ribonucleic acid interference therapies for patients with rare genetic, cardiovascular and liver diseases through a proprietary gene-silencing technology platform.